Location History:
- Tuscon, AZ (US) (1996 - 2000)
- Tucson, AZ (US) (1994 - 2010)
Company Filing History:
4 out of 23 
2 out of 2 
1 out of 1 Years Active: 1994-2010
Title: Innovations in Pediatric Inhalation Therapy: The Contributions of Mark B Mecikalski
Introduction
Mark B Mecikalski, an inventor based in Tucson, AZ, has made significant strides in the field of inhalation therapy, particularly for infants. With a portfolio of 10 patents, his work focuses on enhancing drug delivery systems through innovative design and functionality. His latest patents aim to simplify the process of medication administration for both patients and caregivers.
Latest Patents
Mecikalski’s recent inventions include a drug transfer device designed to facilitate the inhalation of powdered medication into a patient’s respiratory system. This system features a drug container that easily inserts into an inhaler device, allowing for a smooth flow of medication as the patient inhales, without the need for complicated maneuvers.
Another noteworthy invention is the infant inhaler, which communicates aerosol medication through a flexible bag. During inhalation, the medicated air is drawn into the infant's lungs while exhaled air is released into the atmosphere. This user-friendly design enables caregivers to monitor medication administration by observing the deflation of the flexible bag, all while comfortably cradling the infant in their other arm. The apparatus also allows for easy refilling with either ambient air or medication using just one hand.
Career Highlights
Mecikalski has had a prominent career, contributing his expertise to notable organizations such as Dura Pharmaceuticals, Inc. His work has not only advanced inhalation therapies but has also paved the way for future innovations in the medical device industry.
Collaborations
Throughout his career, Mark B Mecikalski has collaborated with esteemed colleagues, including David R Williams and David O Thueson. These collaborations have fostered an environment of creativity and problem-solving, driving the development of more efficient medical delivery systems.
Conclusion
Mark B Mecikalski’s contributions to inhalation therapy are remarkable and reflect a dedication to improving the ease and effectiveness of medication delivery, especially for vulnerable populations like infants. His innovative designs and collaborative efforts continue to set the standard in the industry, making significant impacts on patient care and medication administration.